All correspondence should be mailed to the ABMGG Administrative Office at the following address:

6120 Executive Blvd., Suite 525, Rockville, MD, 20852

Phone: (301) 634-7315

Email: abmgg@abmgg.org

For inquiries regarding:

Credentials and Certification: For individuals who have questions regarding eligibility to sit for an ABMGG certification exam: credentials@abmgg.org

Continuing Certification: For ABMGG diplomates who have questions about maintaining their certification: StayCertified@abmgg.org

CertLink: For questions/issues regarding ABMGG’s longitudinal assessment: abmgg@mycertlink.org

Staff contact information:

Azra Ligon, PhD, Chief Executive Officer

aligon@abmgg.org | (301) 634-7315


Darrel Waggoner, MD, Associate Chief Executive Officer

dwaggoner@abmgg.org __________________________________________________________________

Miriam (Mimi) Blitzer, PhD, FACMG, Chief Executive Officer Emerita

mblitzer@abmgg.org


Stacie Miller, MS, CAE, Chief Administrative Officer

smiller@abmgg.org | (301) 634-7425


Tamika Edaire, Communications and Diplomate Relations Specialist

tedaire@abmgg.org | (301) 634-7317


Dia Pellerin, Administrative Coordinator

dpellerin@abmgg.org | (301) 634-7316


Facebook Posts

Join ABMGG Diplomate, Dr. Rebecca Ahrens-Nicklas, next Wednesday at 12pm ET, for a webinar exploring the development of platform-based gene editing and gene replacement therapies for rare inborn errors of metabolism. Registration is free and can be found at the link below:Join Genetics in Medicine and GIM Open for a free webinar “Advancing Platform Genomic Therapies for Inborn Errors of Metabolism,” on July 30, 12 – 1PM ET. Featuring Dr. Rebecca Ahrens-Nicklas of the Children's Hospital of Philadelphia, the webinar will focus on the development of platform-based gene editing and gene replacement therapies for rare inborn errors of metabolism.Dr. Ahrens-Nicklas will discuss the rapid translation from proof-of-concept studies to a first-in-human trial of a customized gene editing therapy for an infant with severe, neonatal-onset #CPS1 deficiency. Register today: bit.ly/46KkVA8 #GeneEditing See MoreSee Less
View on Facebook
ABMGG Diplomate, Dr. Rebecca Ahrens-Nicklas, was recently featured in The New York Times for her work at Children's Hospital of Philadelphia. Her patient, a baby with CPS1 deficiency, was treated using the world’s first custom gene-editing therapy. Read the full article here: shorturl.at/1Ym0P See MoreSee Less
View on Facebook
Be sure to check your inbox for our Summer 2025 newsletter. Read the latest on ACGME combined programs, diplomate highlights and more! 📰 See MoreSee Less
View on Facebook